OpenVSafe by OpenVAERS
Search V-safe

B6F-20409-56971

1 vaccination 3 coded responses 12 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
56-60
ZIP prefix
449 / OH
Registered
2021-03-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-12
    Registered in v-safe
  2. 2021-03-12
    Dose 1 — Moderna
  3. 2021-03-12
    Health check-in — day 0, dose 1
    Feeling: Good · Muscle or body aches
    Adult check-in
  4. 2021-03-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Muscle or body aches
    Adult check-in
  5. 2021-03-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-19
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-03-26
    Survey response — day 14, dose 1
    MedDRA: Chest pain, Chills, Fibromyalgia, Insomnia, Neck pain, Pain in extremity, Pleurisy — Feeling: Fair · Be unable to work
    Free text: Chills, fibromyalgia pain returned in neck, base of skull, & hands for 48 hours,Pleurisy symptoms in right lung 24 hours then became diffuse to middle chest past three days. Difficult to sleep
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-02
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-09-10
    Survey response — 6 months, dose 1
    MedDRA: Bronchitis, Headache, Inflammation, Pyrexia — Feeling: Fair · Be unable to work or attend school
    Free text: Fever for two days this week and headache earlier todayI have had a lot of chest/ bronchial inflammation
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-03-12
    Survey response — 12 months, dose 1
    MedDRA: General physical health deterioration, Guillain-Barre syndrome, Mobility decreased — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    Free text: Symptoms: Diagnosed with Guillain-Barre back in December with lingering symptoms · Healthcare visit (other): Weekly diminished health and mobility with symptoms progressing every three to five days
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-03-12
    Report sent to call center — 12 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  16. 2022-03-16
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-03-12Moderna

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 6 — day 14, dose 1

2021-03-26

Symptoms: Chills, fibromyalgia pain returned in neck, base of skull, & hands for 48 hours,Pleurisy symptoms in right lung 24 hours then became diffuse to middle chest past three days. Difficult to sleep

Release 9 — 6 months, dose 1

2021-09-10

Symptoms: Fever for two days this week and headache earlier todayI have had a lot of chest/ bronchial inflammation

Release 11 — 12 months, dose 1

2022-03-12

Symptoms: Diagnosed with Guillain-Barre back in December with lingering symptoms
Healthcare visit (other): Weekly diminished health and mobility with symptoms progressing every three to five days

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOGeneral physical health deterioration · · ✓
HCVOMobility decreased · · ✓
SDBronchitis · · ✓
SDChest pain ✓ ✓ ✓
SDChills ✓ ✓ ✓
SDFibromyalgia ✓ ✓ ✓
SDGuillain-Barre syndrome · · ✓
SDHeadache · · ✓
SDInflammation · · ✓
SDInsomnia ✓ ✓ ✓
SDNeck pain ✓ ✓ ✓
SDPain in extremity ✓ ✓ ✓
SDPleurisy ✓ ✓ ✓
SDPyrexia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release